0001140361-24-013494.txt : 20240315 0001140361-24-013494.hdr.sgml : 20240315 20240315160523 ACCESSION NUMBER: 0001140361-24-013494 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Sean C. CENTRAL INDEX KEY: 0001801993 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 24754690 MAIL ADDRESS: STREET 1: C/O VERICEL CORPORATION STREET 2: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4/A 1 form4.xml FORM 4/A X0508 4/A 2024-03-08 2024-03-11 0000887359 Vericel Corp VCEL 0001801993 Flynn Sean C. 64 SIDNEY STREET CAMBRIDGE MA 02139 true SVP, General Counsel true Common Stock 2024-03-08 4 S 0 8115 45.33 D 167 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2023. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). On March 11, 2024, a Form 4 was filed reporting a sale of 8,115 shares for the reporting person. The sale was conducted pursuant to a Rule 10b5-1(c) plan, however, the Rule 10b5-1(c) Transaction Indication was inadvertently not checked. This Form 4/A is being filed to correct the error, and reflects the sale of 8,115 shares pursuant to the reporting person's Rule 10b5-1(c) plan. /s/ Sean Flynn 2024-03-15